Since 2013, the World Alliance Forum in San Francisco (WAFSF) has focused on the commercialization and industrialization of new technologies in healthcare fields such as regenerative medicine, gene therapy, cancer immunotherapy, and digital health.
2017 WAFSF highlights dramatic new innovations in the lab, clinic, at the regulatory level, and in finance, that will help pave a new path in the era of aging population and chronic diesases. It includes presentations from lawmakers regarding new laws and regulatory pathways designed to deliver better healthcare, and business leaders who will discuss new business and financing models. In addition, the conference will feature presentations from top-tier regenerative medicine, gene therapy, and digital health companies and researchers. Esteemed thought leaders will also discuss how companies and universities can continue to foster innovation and bring game changing therapeutics to the market.
Immersion in the active discussions by leading visionaries and unique attendee composition at WAFSF encourages cross-industry, cross-sector, and cross-boarder collaborations, which makes WAFSF an important destination for business development.
Every year, WAFSF is proud to host the world’s leading figures and visionaries in the field. Nobel laureates such as Dr. Shinya Yamanaka and Dr. Paul Berg are frequent speakers, as well as executives of small and large companies and industry groups. For more visit see our speakers.
From trending innovations and startups and funding and commercialization strategies to new regulatory frameworks, discussions at WAFSF are active, exciting, comprehensive, and interdisciplinary.
Attendees represent different industries, research institutions, and governmental agencies from the US, Japan, and beyond. This unique composition of attendees make way for new ideas and have resulted in multiple collaboration and partnership deals.